Hepatitis C virus treatment in the real world: optimising treatment and access to therapies
Authors:
Open Access
Abstract
Chronic HCV infections represent a major worldwide public health problem and are responsible for a large proportion of liver related deaths, mostly because of HCV-associated hepatocellular carcinoma and cirrhosis. The treatment of HCV has undergone a rapid and spectacular revolution. In the past 5 years, the launch of direct acting antiviral drugs has seen sustained virological response rates reach 90% and above for many patient groups. The new treatments are effective, well tolerated, allow for shorter treatment regimens and offer new opportunities for previously excluded groups. This therapeutic revolution has changed the rules for treatment of HCV, moving the field towards an interferon-free era and raising the prospect of HCV eradication. This manuscript addresses the new challenges regarding treatment optimisation in the real world, improvement of antiviral efficacy in ‘hard-to-treat’ groups, the management of patients whose direct acting antiviral drug treatment was unsuccessful, and access to diagnosis and treatment in different parts of the world.Keywords
This publication has 80 references indexed in Scilit:
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment OptionsNew England Journal of Medicine, 2013
- Sofosbuvir for Previously Untreated Chronic Hepatitis C InfectionNew England Journal of Medicine, 2013
- Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical TrialsClinical Infectious Diseases, 2013
- Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalenceHepatology, 2013
- Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World SettingPLOS ONE, 2013
- Assessing long-term treatment efficacy in chronic hepatitis B and C: Between evidence and common senseJournal of Hepatology, 2012
- New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectivesGut, 2012
- New challenges in viral hepatitisGut, 2012
- A French prospective observational study of the treatment of chronic hepatitis C in drug abusersGastroentérologie Clinique Et Biologique, 2008
- Hepatitis C Virus–Related Cirrhosis as a Significant Mortality Factor in Intention-to-Treat Analysis in Liver TransplantationTransplantation Proceedings, 2007